Table E2.
Study | Year | Cost-effectiveness ratio (US dollars) |
---|---|---|
Cost-Effectiveness of Implantable Cardioverter-DefibrillatorsE1 | 2005 | $34,000-$70,200/QALY |
Cost-Effectiveness of Remote Cardiac Monitoring with the CardioMEMS Heart Failure SystemE2 | 2017 | $44,832/QALY |
Cost-Effectiveness analysis of mitral valve repair with the MitraClip delivery system for patients with mitral regurgitation: a systematic reviewE3 | 2021 | $55,600/QALY |
Cost-Effectiveness of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease and Acute Coronary Syndromes in the US Medicare ProgramE4 | 2021 | $101,565/QALY CABG |
Cost-Effectiveness of Transcatheter vs Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Intermediate RiskE5 | 2017 | $44,062/QALY TAVR vs 46,968/QALY SAVR |
QALY, Quality-adjusted life years; CABG, coronary artery bypass grafting; TAVR, transcatheter aortic valve replacement; SAVR, surgical aortic valve replacement.